Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
09/2012
09/25/2012US8273324 Embolization
09/25/2012CA2512310C Improved linkers for radiopharmaceutical compounds
09/25/2012CA2478049C Humanized antibodies that recognize beta amyloid peptide
09/20/2012WO2012124998A2 Bio-pin
09/20/2012WO2012124502A1 Metal nanoparticles and imaging agent containing same
09/20/2012WO2012123229A1 Solid, negative x-ray contrast medium for depicting the gastrointestinal tract
09/20/2012WO2011031915A9 Azulene and azaazulene systems for imaging, monitoring and therapy
09/20/2012US20120240288 Control of pests in plants
09/20/2012US20120238867 Method and apparatus for examining tissue for predefined target cells, particularly cancerous cells, and a probe useful in such method and apparatus
09/20/2012US20120237451 Novel molecular beacons
09/20/2012US20120237450 Stabilized Ultrasound Contrast Agent
09/20/2012US20120237449 Methods for treating neural cell swelling
09/20/2012US20120237448 Sphingosine kinase type 1 inhibitors, and processes for using same
09/20/2012US20120237447 Star polymer nanoshells and methods of preparation thereof
09/20/2012CA2830407A1 Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
09/19/2012EP2500040A1 Improved Gastrin Releasing Peptide Receptor-Binding Compounds
09/19/2012EP2499485A1 Ovarian markers of oocyte competency and uses thereof
09/19/2012EP2498826A1 Labelled pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their use in diagnostic methods
09/19/2012CN102686519A Magnetite in nanoparticulate form
09/19/2012CN102686518A Magnetic iron oxide microparticle powder, aqueous dispersion containing magnetic particles, and process for production of same
09/19/2012CN102671217A Preparation of CT/MR bimodal imaging nano contrast medium with folate targeting function
09/19/2012CN102671216A Application of manganese salt and chelate thereof in preparation of magnetic resonance contrast agent for diagnosing liver injury
09/19/2012CN102670577A Photo-sensitizer composition, and using method and application thereof
09/19/2012CN102199625B Construction method for miRNA (micro Ribonucleic Acid) transgenic mouse model
09/19/2012CN101991569B Rhesus monkey temporal lobe epilepsy kindling model and drug screening method thereof
09/18/2012US8268358 Use of simple amino acids to form porous particles
09/18/2012US8268312 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
09/18/2012US8268291 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
09/18/2012CA2580080C Methods for antibody library screening
09/18/2012CA2549890C Mri contrast medium composition for oral administration
09/18/2012CA2533321C Bicyclic peptide imaging agents
09/18/2012CA2522326C Bifunctional tridentate pyrazolyl containing ligands for re, tc and mn tricarbonyl complexes
09/18/2012CA2448647C Developmental animal model of temporal lobe epilepsy
09/13/2012WO2012121528A2 Magnetic nanocomposite specific for thyroid cancer and use thereof
09/13/2012WO2012121430A1 Carboxylic mannan-coated contrast agent for magnetic resonance imaging
09/13/2012WO2012120124A1 Factor xii inhibitors for the treatment of silent brain ischemia and ischemia of other organs
09/13/2012WO2012120004A1 In vivo selection of therapeutically active antibodies
09/13/2012WO2012119999A1 Means and methods for in vivo testing of therapeutic antibodies
09/13/2012WO2012073047A3 Compositions and methods
09/13/2012US20120232463 De novo synthesis of bacteriochlorins
09/13/2012US20120231038 Wound Healing Compositions Comprising Biocompatible Cellulose Hydrogel Membranes and Methods of Use Thereof
09/13/2012US20120230919 Mri contrast agent coated with carboxylated mannan and method for producing the same
09/13/2012US20120230917 Compositions that include a hydrophobic compound and a polyamino acid conjugate
09/13/2012US20120230916 Compositions Comprising Enzyme-Cleavable Ketone-Modified Opioid Prodrugs and Optional Inhibitors Thereof
09/13/2012US20120230915 Composition and method for medical imaging of body cavities
09/13/2012US20120230914 Labeling compound for pet
09/13/2012US20120230913 Protein nanoparticle dispersions
09/13/2012US20120230912 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
09/13/2012DE102011005444A1 Festes, negatives Röntgenkontrastmittel zur Darstellung des Gastrointestinaltraktes Solid, negative X-ray contrast media for visualization of the gastrointestinal tract
09/13/2012CA2829128A1 Factor xii inhibitors for the treatment of silent brain ischemia and ischemia of other organs
09/12/2012EP2497489A1 Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs
09/12/2012EP2496562A1 Process for the preparation of calcobutrol
09/12/2012EP2496269A1 Quantifying cell death
09/12/2012CN102666576A Peptides that bind the alpha-fetoprotein (AFP) receptor and uses thereof
09/12/2012CN102665536A Determining the liver function by quantitatively measuring the metabolism of substrates
09/12/2012CN102659945A Anti-C5aR antibodies and uses thereof
09/12/2012CN102657881A Fe3O4 nano-magnetic resonance contrast medium material and preparation method thereof
09/12/2012CN102657880A Quaternized chitosan/siRNA (small interfering Ribonucleic Acid) composite particles and preparation method thereof
09/12/2012CN102657872A Multifunctional graphene oxide/ polyamide-amine (PAMAM)/ diethylene triamine pentaacetic-gadolinium (DTPA-Gd)/ prostate stem cell antigen (PSCA) antibody material and preparation method and application thereof
09/11/2012US8263358 Intracellular nanosensors and methods for their introduction into cells
09/11/2012US8263077 Cell growth inhibitors containing anti-glypican 3 antibody
09/11/2012US8263042 Contrast agents for myocardial perfusion imaging
09/11/2012US8263041 Antigen associated with the neovasculature of tumour metastases
09/11/2012CA2506296C Water-soluble anionic bacteriochlorophyll derivatives and their uses
09/11/2012CA2451065C Enzymatic method of producing 4-0-beta-d-galactopyranosyl-d-xylose
09/07/2012WO2012119102A2 Homeopathic therapeutic method and compositions
09/07/2012WO2012118930A2 Stable colloidal gold nanoparticles with controllable surface modification and functionalization
09/07/2012WO2012118715A2 Non-peptidic quenched fluorescent imaging probes
09/07/2012WO2012118547A1 Novel modulators and methods of use
09/07/2012WO2012118136A1 Switching-type fluorescent nanoparticle probe, and fluorescent molecular imaging method using same
09/07/2012WO2012049453A3 Compositions for topical applications
09/07/2012CA2828883A1 Homeopathic therapeutic method and compositions
09/07/2012CA2820885A1 Novel modulators and methods of use
09/06/2012US20120225848 Antagonists of GABA-B Receptors to Enhance Neuronal Function, Learning and Memory
09/06/2012US20120225022 Dental cleaning composition for orthodontic patients
09/06/2012US20120225021 Stable colloidal gold nanoparticles with controllable surface modification and functionalization
09/06/2012US20120225020 Unsaturated choline analogs and chemical synthesis thereof
09/06/2012US20120225019 Dual Fluorescence Assay For Determining Viability Of Parasitic Or Non-Parasitic Worms
09/06/2012US20120225018 Homeopathic therapeutic method and compositions
09/06/2012US20120225017 Mixed micelles
09/06/2012US20120225015 Method for predicting autism spectrum disorders by cannabinoid and cannabinoid receptor expression
09/05/2012EP2495563A1 Diagnostic agent for infectious diseases
09/05/2012EP2494918A1 Method for detecting endogenous biomolecule
09/05/2012EP2493512A2 Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents
09/05/2012EP2493511A1 Diagnostic composition comprising plasma cations having superior safety profile
09/05/2012CN102652838A Method for detecting curative effect of ornidazole for resisting against bacteroides fragilis infection
09/05/2012CN102233139B Acetylcysteine effervescent tablet and preparation method and application thereof
09/05/2012CN102112158B Biocompatible polymer and magnetic nanoparticle with biocompatibility
09/05/2012CN102085380B Preparation method of nano magnetic particles for detection and treatment of coronary heart diseases
09/05/2012CN102028959B Preparation method of tumor targeting paramagnetic liposome for magnetic resonance diagnosis
09/05/2012CN101805362B Porphyrin modified by diethylenetriamine pentaacetic acid gadolinium and preparation method and application thereof
09/05/2012CN101389356B Drug delivery material
09/05/2012CN101262891B Measurement of gastric acid secretion
09/04/2012US8258102 Gene and polypeptide sequences
09/04/2012US8258101 Peptide-based compounds
09/04/2012US8257735 Method of increasing the bioavailability of recombinant human insulin isophane in a patient
09/04/2012US8257716 Anti-PDEF antibodies and uses thereof
09/04/2012US8257683 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
09/04/2012CA2528411C Method for improving stability and shelf-life of liposome complexes
09/04/2012CA2510531C Compositions of magnetic particles covered with gem-bisphosphonate derivatives
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 354